Published in Lancet on November 11, 2006
Access to medicines from a health system perspective. Health Policy Plan (2012) 2.39
An overview of cardiovascular risk factor burden in sub-Saharan African countries: a socio-cultural perspective. Global Health (2009) 2.09
Leveraging rapid community-based HIV testing campaigns for non-communicable diseases in rural Uganda. PLoS One (2012) 1.77
Adapting the DOTS framework for tuberculosis control to the management of non-communicable diseases in sub-Saharan Africa. PLoS Med (2008) 1.49
Diabetes is a risk factor for pulmonary tuberculosis: a case-control study from Mwanza, Tanzania. PLoS One (2011) 1.39
Diabetes mellitus type 2 in urban Ghana: characteristics and associated factors. BMC Public Health (2012) 1.33
The growing caseload of chronic life-long conditions calls for a move towards full self-management in low-income countries. Global Health (2011) 1.16
Chronic disease management in Sub-Saharan Africa: whose business is it? Int J Environ Res Public Health (2009) 1.11
The co-management of tuberculosis and diabetes: challenges and opportunities in the developing world. PLoS Med (2012) 1.09
HbA1c of 6.5% to diagnose diabetes mellitus -- does it work for us? -- the Bellville South Africa study. PLoS One (2011) 1.02
Management of Chronic Diseases in Sub-Saharan Africa: Cross-Fertilisation between HIV/AIDS and Diabetes Care. J Trop Med (2012) 0.99
Access to medicines versus access to treatment: the case of type 1 diabetes. Bull World Health Organ (2008) 0.91
Use of medical services and medicines attributable to diabetes in Sub-Saharan Africa. PLoS One (2014) 0.87
Preventing diabetes mellitus in developing countries. Nat Rev Endocrinol (2012) 0.86
Poor-quality health services and lack of programme support leads to low uptake of HIV testing in rural Mozambique. Afr J AIDS Res (2012) 0.85
Planning and developing services for diabetic retinopathy in Sub-Saharan Africa. Int J Health Policy Manag (2014) 0.83
Female sex, poverty and globalization as determinants of obesity among rural South African type 2 diabetics: a cross-sectional study. BMC Public Health (2015) 0.82
Glucose control in Rwandan youth with type 1 diabetes following establishment of systematic, HbA1c based, care and education. Diabetes Res Clin Pract (2014) 0.80
Selection of essential medicines for diabetes in low and middle income countries: a survey of 32 national essential medicines lists. PLoS One (2014) 0.80
"In a situation of rescuing life": meanings given to diabetes symptoms and care-seeking practices among adults in Southeastern Tanzania: a qualitative inquiry. BMC Public Health (2015) 0.80
Challenges constraining access to insulin in the private-sector market of Delhi, India. BMJ Glob Health (2016) 0.80
Uncontrolled Hypertension and Its Determinants in Patients with Concomitant Type 2 Diabetes Mellitus (T2DM) in Rural South Africa. PLoS One (2016) 0.80
The perceptions and perspectives of patients and health care providers on chronic diseases management in rural South Africa: a qualitative study. BMC Health Serv Res (2015) 0.78
Comparative functional exercise capacity of patients with type 2-diabetes and healthy controls: a case control study. Pan Afr Med J (2014) 0.77
"It is the medicines that keep us alive": lived experiences of diabetes medication use and continuity among adults in Southeastern Tanzania. BMC Health Serv Res (2015) 0.77
Adherence to anti diabetic medication among patients with diabetes in eastern Uganda; a cross sectional study. BMC Health Serv Res (2015) 0.76
Use of medical services and medicines attributable to type 2 diabetes care in Yaoundé, Cameroon: a cross-sectional study. BMC Health Serv Res (2017) 0.75
Correlates and Predictors of Increasing Waist Circumference in Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study. Int Sch Res Notices (2014) 0.75
Cross-sectional study of patients with type 2 diabetes in OR Tambo district, South Africa. BMJ Open (2016) 0.75
Assessment of health system challenges and opportunities for possible integration of diabetes mellitus and tuberculosis services in South-Eastern Amhara Region, Ethiopia: a qualitative study. BMC Health Serv Res (2016) 0.75
Non-Communicable Disease Mortality and Risk Factors in Formal and Informal Neighborhoods, Ouagadougou, Burkina Faso: Evidence from a Health and Demographic Surveillance System. PLoS One (2014) 0.75
Diabetes in sub-Saharan Africa - from policy to practice to progress: targeting the existing gaps for future care for diabetes. Diabetes Metab Syndr Obes (2017) 0.75
Trunk fat and leg fat have independent and opposite associations with fasting and postload glucose levels: the Hoorn study. Diabetes Care (2004) 3.02
Associations of hip and thigh circumferences independent of waist circumference with the incidence of type 2 diabetes: the Hoorn Study. Am J Clin Nutr (2003) 2.70
Insight into the nature of the CRP-coronary event association using Mendelian randomization. Int J Epidemiol (2006) 2.70
Global health learning outcomes for medical students in the UK. Lancet (2011) 2.68
The association between birth weight and capillary recruitment is independent of blood pressure and insulin sensitivity: a study in prepubertal children. J Hypertens (2002) 2.03
Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome. Diabetes Metab (2002) 1.95
International health graduates--career path experience. Lancet (2012) 1.91
Postgraduate training in global health: ensuring UK doctors can contribute to health in resource-poor countries. Clin Med (2011) 1.78
Access to care for patients with insulin-requiring diabetes in developing countries: case studies of Mozambique and Zambia. Diabetes Care (2005) 1.78
Humoral markers of inflammation and endothelial dysfunction in relation to adiposity and in vivo insulin action in Pima Indians. Atherosclerosis (2002) 1.60
Larger thigh and hip circumferences are associated with better glucose tolerance: the Hoorn study. Obes Res (2003) 1.48
The Y-Y paradox. Lancet (2004) 1.44
International Health Electives: Four years of experience. Travel Med Infect Dis (2004) 1.38
Getting the message across: mechanisms of physiological cross talk by adipose tissue. Am J Physiol Endocrinol Metab (2009) 1.29
Regional body composition as a determinant of arterial stiffness in the elderly: The Hoorn Study. J Hypertens (2004) 1.28
Conceptualising global health: theoretical issues and their relevance for teaching. Global Health (2012) 1.22
Regulation of vascular function and insulin sensitivity by adipose tissue: focus on perivascular adipose tissue. Microcirculation (2007) 1.18
The evolution of global health teaching in undergraduate medical curricula. Global Health (2012) 1.17
Looking beyond the issue of access to insulin: what is needed for proper diabetes care in resource poor settings. Diabetes Res Clin Pract (2010) 1.14
Perivascular adipose tissue control of insulin-induced vasoreactivity in muscle is impaired in db/db mice. Diabetes (2012) 1.13
Assessing health systems for type 1 diabetes in sub-Saharan Africa: developing a 'Rapid Assessment Protocol for Insulin Access'. BMC Health Serv Res (2006) 1.05
Vascular effects of improving metabolic control with metformin or rosiglitazone in type 2 diabetes. Diabetes Care (2004) 1.03
Perivascular adipose tissue and its role in type 2 diabetes and cardiovascular disease. Curr Diab Rep (2011) 0.97
Metformin and its liver targets in the treatment of type 2 diabetes. Curr Drug Targets Immune Endocr Metabol Disord (2003) 0.95
Haematocrit, type 2 diabetes, and endothelium-dependent vasodilatation of resistance vessels. Eur Heart J (2005) 0.94
On the road to the insulin centenary. Lancet (2012) 0.92
Access to medicines versus access to treatment: the case of type 1 diabetes. Bull World Health Organ (2008) 0.91
Diabetes in Kyrgyzstan: changes between 2002 and 2009. Int J Health Plann Manage (2012) 0.89
Licensing drugs for diabetes. BMJ (2010) 0.88
Visceral and truncal subcutaneous adipose tissue are associated with impaired capillary recruitment in healthy individuals. J Clin Endocrinol Metab (2006) 0.88
Prospective relation of C-reactive protein with type 2 diabetes: response to Han et al. Diabetes Care (2003) 0.87
Preventing stroke with ramipril. Superiority of particular class of antihypertensive agent remains to be shown. BMJ (2002) 0.85
The International Diabetes Federation: losing its credibility by partnering with Nestlé? Lancet (2012) 0.84
Effects of fish oil on lipid profile and other metabolic outcomes in HIV-infected patients on antiretroviral therapy: a randomized placebo-controlled trial. Int J STD AIDS (2013) 0.83
Development of coronary heart disease and ischemic stroke in relation to fasting and 2-hour plasma glucose levels in the normal range. Cardiovasc Diabetol (2012) 0.83
Conventional and novel cardiovascular risk factors and markers of vascular damage in rural and urban Indian men. Int J Cardiol (2011) 0.83
Twinning for better diabetes care: a model for improving healthcare for non-communicable diseases in resource-poor countries. Postgrad Med J (2009) 0.82
TNF-alpha levels are associated with skin capillary recruitment in humans: a potential explanation for the relationship between TNF-alpha and insulin resistance. Clin Sci (Lond) (2006) 0.81
Effect of Interleukin-6 promoter polymorphisms in survivors of myocardial infarction and matched controls in the North and South of Europe. The HIFMECH Study. Thromb Haemost (2004) 0.81
'Hard,' 'soft' and 'surrogate' endpoints in diabetes. J Epidemiol Community Health (2012) 0.79
Plasminogen activator inhibitor-1 (PAI-1) activity post myocardial infarction: the role of acute phase reactants, insulin-like molecules and promoter (4G/5G) polymorphism in the PAI-1 gene. Atherosclerosis (2003) 0.79
Post-load hyperglycaemia-an inappropriate therapeutic target. Lancet (2002) 0.79
Life-course socio-economic factors, skin colour and abdominal obesity in adulthood in a Brazilian birth cohort. Public Health Nutr (2009) 0.79
Insulin-induced changes in skeletal muscle microvascular perfusion are dependent upon perivascular adipose tissue in women. Diabetologia (2015) 0.78
Hyperglycaemia as a cardiovascular risk factor in diabetes. Lancet (2008) 0.77
Confounders in chronic stress at work and metabolic syndrome. BMJ (2006) 0.77
Intensive treatment of hyperglycaemia: what are the objectives? Lancet (2010) 0.77
European Medicines Agency must take account of cardiovascular harm associated with degludec insulin. BMJ (2013) 0.76
What are editors for? Lancet (2012) 0.76
Commentary: Politics of affordable insulin. BMJ (2011) 0.76
Glucagon-like peptide-1 drugs. Use of GLP-1 analogues needs great caution. BMJ (2011) 0.76
Perivascular fat in human muscle. Lancet Diabetes Endocrinol (2016) 0.76
Olmesartan, microalbuminuria, and type 2 diabetes. N Engl J Med (2011) 0.75
Very tight glucose control: May be high risk, low benefit. BMJ (2008) 0.75
A theme issue by, for, and about Africa: tackling the challenge of diabetes. BMJ (2005) 0.75
Concerns about meta-analysis of glucose control and cardiovascular disease in type 2 diabetes. Ann Intern Med (2010) 0.75
Intensive glucose control and cardiovascular outcomes. Lancet (2009) 0.75
Increased proinsulin concentrations and excess risk of coronary heart disease in patients with diabetes and prediabetes. Circulation (2002) 0.75
Global reality of type 1 diabetes care in 2013. Diabetes Care (2013) 0.75
ADDITION-Europe and the case for diabetes screening. Lancet (2012) 0.75
The DREAM trial. Lancet (2006) 0.75
Prognosis of diabetes in the developing world. Lancet (2003) 0.75
Hard end points are needed for intensive glycaemic control in patients with type 2 diabetes. BMJ (2012) 0.75
Apply criteria to improve health systems in developing countries. BMJ (2012) 0.75
PROactive study. Lancet (2006) 0.75
Self management of diabetes. Fallacy in intervention model. BMJ (2010) 0.75
Medical complicity in torture. Time for WMA to take action. BMJ (2010) 0.75
Care of refused asylum seekers. Bad news for everyone. BMJ (2009) 0.75
Into the therapeutics void. Let us protest loudly. BMJ (2009) 0.75
Lack of impact of angiotensin-converting enzyme gene polymorphism and salt intake on insulin resistance and limb blood flow. Clin Endocrinol (Oxf) (2014) 0.75
Common variants in the thrombomodulin gene as a risk for myocardial infarction in the north of Europe (HIFMECH Study). Thromb Haemost (2004) 0.75